| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:35 UTC |
|---|
| HMDB ID | HMDB0014367 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Glimepiride |
|---|
| Description | Glimepiride is only found in individuals that have used or taken this drug. It is the first III generation sulphonyl urea it is a very potent sulphonyl urea with long duration of action.The mechanism of action of glimepiride in lowering blood glucose appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin. Glimepiride likely binds to ATP-sensitive potassium channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Membrane depolarization stimulates calcium ion influx through voltage-sensitive calcium channels. This increase in intracellular calcium ion concentration induces the secretion of insulin. |
|---|
| Structure | CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC2CCC(C)CC2)C1=O InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30) |
|---|
| Synonyms | | Value | Source |
|---|
| Amaryl | Kegg | | Glimepirid | HMDB | | Glimepirida | HMDB | | Glimepiridum | HMDB | | Glimepride | HMDB | | 1-(4-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrrolinecarboxamido)ethyl)phenylsulfonyl)-3-(4-methylcyclohexyl)urea | HMDB | | Aventis pharma brand OF glimepiride | HMDB | | Hoechst brand OF glimepiride | HMDB | | Aventis behring brand OF glimepiride | HMDB | | Roname | HMDB | | Amarel | HMDB | | Aventis brand OF glimepiride | HMDB | | Glymepiride | HMDB | | HOE 490 | HMDB | | HOE-490 | HMDB | | Lacer brand OF glimepiride | HMDB | | 3-Ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)-C-hydroxycarbonimidoyl]amino}sulfonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboximidate | Generator | | 3-Ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)-C-hydroxycarbonimidoyl]amino}sulphonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboximidate | Generator | | 3-Ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)-C-hydroxycarbonimidoyl]amino}sulphonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboximidic acid | Generator |
|
|---|
| Chemical Formula | C24H34N4O5S |
|---|
| Average Molecular Weight | 490.616 |
|---|
| Monoisotopic Molecular Weight | 490.224990908 |
|---|
| IUPAC Name | 3-ethyl-4-methyl-N-{2-[4-({[(4-methylcyclohexyl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide |
|---|
| Traditional Name | glimepiride |
|---|
| CAS Registry Number | 93479-97-1 |
|---|
| SMILES | CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC2CCC(C)CC2)C1=O |
|---|
| InChI Identifier | InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30) |
|---|
| InChI Key | WIGIZIANZCJQQY-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzenesulfonamides |
|---|
| Direct Parent | Benzenesulfonamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzenesulfonamide
- Benzenesulfonyl group
- N-acyl urea
- Sulfonylurea
- Ureide
- Pyrroline
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Aminosulfonyl compound
- Isourea
- Carboximidic acid derivative
- Carboxylic acid derivative
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboximidamide
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Hydrocarbon derivative
- Carbonyl group
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 207 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.038 g/L | Not Available | | LogP | 3.5 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections| Adduct Type | Data Source | CCS Value (Å2) | Reference |
|---|
| [M+H]+ | CBM | 216.6 | 30932474 |
|
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.43 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 14.3264 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.41 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2452.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 199.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 205.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 172.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 140.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 555.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 580.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 128.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1158.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 570.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1737.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 336.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 371.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 264.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 160.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 17.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Glimepiride,1TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)[Si](C)(C)C)C1=O | 4008.4 | Semi standard non polar | 33892256 | | Glimepiride,1TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)[Si](C)(C)C)C1=O | 3670.4 | Standard non polar | 33892256 | | Glimepiride,1TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)[Si](C)(C)C)C1=O | 5406.2 | Standard polar | 33892256 | | Glimepiride,1TMS,isomer #2 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C)C=C2)C1=O | 4039.5 | Semi standard non polar | 33892256 | | Glimepiride,1TMS,isomer #2 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C)C=C2)C1=O | 3675.5 | Standard non polar | 33892256 | | Glimepiride,1TMS,isomer #2 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C)C=C2)C1=O | 5425.6 | Standard polar | 33892256 | | Glimepiride,1TMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C)C=C2)C1=O | 4049.8 | Semi standard non polar | 33892256 | | Glimepiride,1TMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C)C=C2)C1=O | 3739.5 | Standard non polar | 33892256 | | Glimepiride,1TMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C)C=C2)C1=O | 5371.3 | Standard polar | 33892256 | | Glimepiride,2TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 3848.4 | Semi standard non polar | 33892256 | | Glimepiride,2TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 3816.1 | Standard non polar | 33892256 | | Glimepiride,2TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 5266.0 | Standard polar | 33892256 | | Glimepiride,2TMS,isomer #2 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 3867.6 | Semi standard non polar | 33892256 | | Glimepiride,2TMS,isomer #2 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 3873.4 | Standard non polar | 33892256 | | Glimepiride,2TMS,isomer #2 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 5143.7 | Standard polar | 33892256 | | Glimepiride,2TMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)C1=O | 3880.8 | Semi standard non polar | 33892256 | | Glimepiride,2TMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)C1=O | 3922.3 | Standard non polar | 33892256 | | Glimepiride,2TMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)C1=O | 5136.9 | Standard polar | 33892256 | | Glimepiride,3TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 3769.9 | Semi standard non polar | 33892256 | | Glimepiride,3TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 4065.8 | Standard non polar | 33892256 | | Glimepiride,3TMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C)[Si](C)(C)C)C=C2)[Si](C)(C)C)C1=O | 4913.8 | Standard polar | 33892256 | | Glimepiride,1TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 4216.9 | Semi standard non polar | 33892256 | | Glimepiride,1TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 3869.0 | Standard non polar | 33892256 | | Glimepiride,1TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 5448.3 | Standard polar | 33892256 | | Glimepiride,1TBDMS,isomer #2 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 4262.6 | Semi standard non polar | 33892256 | | Glimepiride,1TBDMS,isomer #2 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 3877.2 | Standard non polar | 33892256 | | Glimepiride,1TBDMS,isomer #2 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 5447.2 | Standard polar | 33892256 | | Glimepiride,1TBDMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 4292.4 | Semi standard non polar | 33892256 | | Glimepiride,1TBDMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 3973.6 | Standard non polar | 33892256 | | Glimepiride,1TBDMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 5377.1 | Standard polar | 33892256 | | Glimepiride,2TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 4286.7 | Semi standard non polar | 33892256 | | Glimepiride,2TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 4217.5 | Standard non polar | 33892256 | | Glimepiride,2TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)NC3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 5268.1 | Standard polar | 33892256 | | Glimepiride,2TBDMS,isomer #2 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 4295.2 | Semi standard non polar | 33892256 | | Glimepiride,2TBDMS,isomer #2 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 4291.9 | Standard non polar | 33892256 | | Glimepiride,2TBDMS,isomer #2 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)NC(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 5140.8 | Standard polar | 33892256 | | Glimepiride,2TBDMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 4360.3 | Semi standard non polar | 33892256 | | Glimepiride,2TBDMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 4369.7 | Standard non polar | 33892256 | | Glimepiride,2TBDMS,isomer #3 | CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C1=O | 5132.8 | Standard polar | 33892256 | | Glimepiride,3TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 4435.9 | Semi standard non polar | 33892256 | | Glimepiride,3TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 4703.2 | Standard non polar | 33892256 | | Glimepiride,3TBDMS,isomer #1 | CCC1=C(C)CN(C(=O)N(CCC2=CC=C(S(=O)(=O)N(C(=O)N(C3CCC(C)CC3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)C1=O | 4945.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Glimepiride GC-MS (Non-derivatized) - 70eV, Positive | splash10-057r-8927300000-4b19465ae6452def91b6 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Glimepiride GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Glimepiride GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride LC-ESI-QFT , negative-QTOF | splash10-004i-0092300000-285644d8691c9bbbb3c1 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride LC-ESI-QFT , positive-QTOF | splash10-0fb9-0904000000-d6963d3854c74729a002 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 20V, Positive-QTOF | splash10-0h09-0049400000-e3bb982b8c808c02a995 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 20V, Negative-QTOF | splash10-0h09-0049400000-0631be1ca44633419649 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 30V, Negative-QTOF | splash10-004i-0093000000-b095deddf26c757a56db | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 40V, Negative-QTOF | splash10-004i-0090000000-2f31dbba814d4fc74d4b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 20V, Positive-QTOF | splash10-0udi-0109000000-caa2d4614781791278a3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 30V, Positive-QTOF | splash10-004i-0905000000-ccc3ed478df3f4bc06b2 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 10V, Positive-QTOF | splash10-0udi-0009400000-c2399edbd79ea939be91 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 35V, Positive-QTOF | splash10-0fb9-0906000000-286016fc46bf76e1fa89 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 40V, Positive-QTOF | splash10-004i-0900000000-54dca52a9e8453ef5a7e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 50V, Positive-QTOF | splash10-004i-0900000000-7b7087bc285c4563d742 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 10V, Negative-QTOF | splash10-000i-0000900000-ae14eaf56e7ba207ec2a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Glimepiride 35V, Negative-QTOF | splash10-01ri-0059800000-900738971106854d7983 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 10V, Positive-QTOF | splash10-0udl-0907600000-4ad0adf1f2779efb32e4 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 20V, Positive-QTOF | splash10-0fb9-1901000000-2e64d2b8b6f32b2f8ca6 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 40V, Positive-QTOF | splash10-0690-8900000000-3dc90b58624dcd446c15 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 10V, Negative-QTOF | splash10-000i-2606900000-d7aa8b2150735c01ffb8 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 20V, Negative-QTOF | splash10-0fmi-1927000000-f832ef63dab58a660832 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 40V, Negative-QTOF | splash10-0229-5900000000-9d6f732c03d4d2775b4c | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 10V, Negative-QTOF | splash10-000i-0001900000-0084efa26b4193acc57d | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 20V, Negative-QTOF | splash10-00di-4900000000-fa88a92f3e9f63b6d794 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 40V, Negative-QTOF | splash10-006w-9610000000-626a1442a6941d8e3bc1 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 10V, Positive-QTOF | splash10-0udi-0309200000-ca1536f76ae138ba2297 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Glimepiride 20V, Positive-QTOF | splash10-0ufr-1934100000-e5415d3e1f6b86b7f26c | 2021-09-23 | Wishart Lab | View Spectrum |
|
|---|